Drug intelligence / Profile preview

l-theanine

Development stage
Phase 1
Lead developer
Taiyo Kagaku
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

L-theanine is a non-protein amino acid primarily found in green tea (Camellia sinensis), black tea, and certain mushrooms. It is available as a purified dietary supplement and has been granted generally recognized as safe (GRAS) status by the US FDA[3][7]. L-theanine crosses the blood-brain barrier and exerts neurophysiological effects including anxiolytic (anxiety-reducing) and calming actions through modulation of inhibitory neurotransmitters, selective serotonin and dopamine regulation, increased alpha brain wave activity, antagonism of glutamate receptors, upregulation of GABA levels, antioxidant effects via enhancement of SOD and CAT enzyme activities, anti-inflammatory properties through inhibition of NF-κB signaling pathways, neuroprotection against oxidative stress-induced damage, potential improvement in sleep quality and cognitive function[5][6][8]. Clinical evidence for its use in anxiety reduction or sleep disorders remains limited; most data are from preclinical or small human studies[3][5].

Brand names
Suntheanine
Other names
theanineγ-glutamylethylamidegamma-glutamylethylamide
02

Targets

GluR (Glutamate receptors)GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on l-theanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on l-theanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call